Bovie Medical Corporation (NYSEMKT:BVX) Can’t Be Less Risky. Short Interest Decreased

June 29, 2017 - By Winifred Garcia

 Bovie Medical Corporation (NYSEMKT:BVX) Can't Be Less Risky. Short Interest Decreased

Investors sentiment decreased to 1.53 in 2016 Q4. Its down 0.91, from 2.44 in 2016Q3. It dropped, as 9 investors sold Bovie Medical Corporation shares while 6 reduced holdings. 11 funds opened positions while 12 raised stakes. 9.00 million shares or 42.24% more from 6.33 million shares in 2016Q3 were reported.
Blackrock Institutional Na has invested 0% in Bovie Medical Corporation (NYSEMKT:BVX). Blackrock Fund Advisors invested in 0% or 75,721 shares. Great Point Prtn Lc invested 2.25% in Bovie Medical Corporation (NYSEMKT:BVX). Bancorporation Of America Corp De holds 1 shares or 0% of its portfolio. Globeflex Cap Lp owns 200 shares. Thompson Davis And Communications accumulated 0.01% or 2,000 shares. Atria Limited Com has 0% invested in Bovie Medical Corporation (NYSEMKT:BVX) for 10,000 shares. Cortina Asset Mngmt Ltd accumulated 0.24% or 1.58M shares. Oberweis Asset Inc reported 65,000 shares. Creative Planning holds 0% or 1,475 shares. Perkins Capital Management reported 2.49% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX). Citadel Advsr Lc stated it has 11,951 shares or 0% of all its holdings. Kcg Hldg holds 0% or 33,527 shares in its portfolio. Geode Mngmt Ltd Company has invested 0% in Bovie Medical Corporation (NYSEMKT:BVX). Vanguard Grp Inc Inc holds 0% or 812,956 shares in its portfolio.

The stock of Bovie Medical Corporation (NYSEMKT:BVX) registered a decrease of 15.68% in short interest. BVX’s total short interest was 118,300 shares in June as published by FINRA. Its down 15.68% from 140,300 shares, reported previously. With 61,800 shares average volume, it will take short sellers 2 days to cover their BVX’s short positions. The short interest to Bovie Medical Corporation’s float is 0.51%.

About 12,891 shares traded. Bovie Medical Corporation (NYSEMKT:BVX) has risen 28.74% since June 29, 2016 and is uptrending. It has outperformed by 12.04% the S&P500.

Bovie Medical Corporation is an energy medical device company. The company has market cap of $71.63 million. The Firm is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It currently has negative earnings. It operates through three divisions: Core, OEM and J-Plasma.

More notable recent Bovie Medical Corporation (NYSEMKT:BVX) news were published by: Businesswire.com which released: “Bovie Medical Corporation to Present at the JMP Securities Life Sciences …” on May 31, 2017, also Businesswire.com with their article: “Bovie Medical Corporation to Release First Quarter 2017 Financial Results on …” published on April 26, 2017, Seekingalpha.com published: “Bovie Medical Corporation’s (BVX) CEO Rob Gershon on Q4 2016 Results …” on March 10, 2017. More interesting news about Bovie Medical Corporation (NYSEMKT:BVX) were released by: Businesswire.com and their article: “Bovie Medical Announce Sales Channel Partnership with CONMED for PlazXactâ„¢” published on January 19, 2017 as well as Seekingalpha.com‘s news article titled: “Bovie Medical: Little Bovie May Be Running With The Big Dogs” with publication date: July 22, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.